Skip to main content
UniHealth

Doctor search

Michael Jacob Chi-Wing Yong, MD

Otolaryngology · Los Angeles

NPI 1467108647

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Office
1

Offices

1 location · Providence Saint Johns Medical Foundation · 282 clinicians in this group

Looking this up.

Hospitals listed: Providence Little Company of Mary Med Ctr Torrance · Saint John'S Health Center. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Yong’s office at (310) 477-5558 to ask if they take your plan before you enroll.

California Medical Board record

Licence A176533 · Current

Licensed to practise in California · since 2022 · expires 2028-02-29 · University of British Columbia Faculty of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Providence Little Company of Mary Med Ctr TorranceTorrance, CAAcute Care Hospital · Voluntary non-profit - Church · No emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 70% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.472, Oct 2024 – Sep 2025
  • Saint John'S Health CenterSanta Monica, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 73% would definitely recommend it
    Overall rating: 4 of 5 starsBetter than the national rate — SSI - Colon Surgery: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Providence Little Company of Mary Med Ctr Torrance

Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 8 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Providence Little Company of Mary Med Ctr Torrance
Clostridium Difficile (C.Diff)Infections0.472BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.09 (0.11 to 2.07) · 1,022 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.9 (0.59 to 1.2)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths129.31 (75.73 to 182.88) · 65 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2 · 36 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths10.3 · 70 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths11 · 141 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths8.4 · 353 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths14.2 · 361 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.5 · 495 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.4 · 3,150 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.19 (0 to 0.39) · 5,786 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.25 (0.06 to 0.45) · 5,832 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths4.21 (2.1 to 6.32) · 1,135 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.81 (0.22 to 3.4) · 375 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.33 (0.8 to 3.86) · 1,086 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.78 (2.28 to 15.28) · 389 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths4.58 (1.19 to 7.98) · 377 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths2 (0.51 to 3.49) · 247 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.3 (0 to 0.93) · 4,918 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.9 · 127 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0No differentOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.892No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.225No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.363No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits14.7 · 283 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits22 · 709 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits10.5 · 149 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits7.9 · 428 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-13.8 · 369 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.6 · 551 casesNoneJul 2023 – Jun 2025
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 130 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.7 · 59 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 168 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits11.8 (8.9 to 15.5) · 642 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.7 to 1.3) · 331 casesNo differentJan 2024 – Dec 2024

What patients said (414 patients answered, 18% of those asked)

Patient survey stars by topic at Providence Little Company of Mary Med Ctr Torrance
Cleanliness3
Nurse communication4
Doctor communication3
Communication about medicines3
Discharge information3
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Providence Little Company of Mary Med Ctr Torrance
Room was "always" clean69%
Nurses "always" communicated well78%
Doctors "always" communicated well75%
Staff "always" explained60%
Yes, staff "did" give patients this information85%
Yes, staff "did" give patients information about help after discharge86%
Doctors "always" explained things so they could understand71%
Doctors "always" listened carefully74%
Doctors "always" treated them with courtesy and respect81%
Patients who gave a rating of "9" or "10" (high)67%
Staff "always" explained new medications75%
Nurses "always" explained things so they could understand74%
Nurses "always" listened carefully76%
Nurses "always" treated them with courtesy and respect85%
"Always" quiet at night45%
"YES", patients would definitely recommend the hospital70%
Staff "always" explained possible side effects46%
Yes, staff "did" give patients information about possible symptoms84%
See every measure and the patient survey for Saint John'S Health Center

Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Saint John'S Health Center
SSI - Colon SurgeryInfections0BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.64 (0 to 1.49) · 1,939 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.6 to 1.12)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths140.49 (93.64 to 187.34) · 101 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.5 · 33 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.7 · 101 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths11.1 · 175 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths8.4 · 412 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths11 · 615 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.3 · 317 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.1 · 3,461 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.23 (0.03 to 0.42) · 8,758 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.18 (0 to 0.36) · 9,150 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths2.57 (0.92 to 4.22) · 3,516 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths2.47 (1.03 to 3.91) · 2,439 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.7 (0.39 to 3) · 3,369 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.55 (3.36 to 13.74) · 2,341 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths6.38 (3.53 to 9.24) · 2,433 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.52 (0.1 to 2.94) · 677 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.25 (0 to 0.81) · 6,775 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths2.3 · 945 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.631No differentOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.6No differentOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections1.069No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.268No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits14 · 174 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19.8 · 434 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.3 · 178 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits1.3 · 458 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits44.4 · 646 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits17 · 605 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits4.6 (3.1 to 6.8) · 246 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.6 (7.7 to 14.4) · 246 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits3.5 · 907 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits11.1 · 27 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 107 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits11.9 (9 to 15.8) · 258 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.7 to 1.1) · 955 casesNo differentJan 2024 – Dec 2024

What patients said (450 patients answered, 24% of those asked)

Patient survey stars by topic at Saint John'S Health Center
Cleanliness4
Nurse communication2
Doctor communication2
Communication about medicines2
Discharge information2
Overall hospital rating3
Quietness3
Recommend hospital4
Share of patients giving the best answer at Saint John'S Health Center
Room was "always" clean75%
Nurses "always" communicated well71%
Doctors "always" communicated well75%
Staff "always" explained57%
Yes, staff "did" give patients this information78%
Yes, staff "did" give patients information about help after discharge77%
Doctors "always" explained things so they could understand69%
Doctors "always" listened carefully74%
Doctors "always" treated them with courtesy and respect81%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand69%
Nurses "always" listened carefully68%
Nurses "always" treated them with courtesy and respect77%
"Always" quiet at night58%
"YES", patients would definitely recommend the hospital73%
Staff "always" explained possible side effects42%
Yes, staff "did" give patients information about possible symptoms79%

Original Medicare doctor bills

$251,953

Medicare paid this office $251,953 for 720 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Diagnostic exam of nasal passages using an endoscope268$56,581$163
Return visit (30+ min)182$25,138$100
New patient visit (45+ min)151$19,114$127
Short return visit (20+ min)180$17,336$73
Biopsy or removal of nasal polyp or tissue using an endoscope28$12,956$288
See all 14 services
Every Original Medicare service billed
Diagnostic exam of nasal passages using an endoscope268$56,581$163
Return visit (30+ min)182$25,138$100
New patient visit (45+ min)151$19,114$127
Short return visit (20+ min)180$17,336$73
Biopsy or removal of nasal polyp or tissue using an endoscope28$12,956$288
New patient visit (30+ min)142$12,080$85
Removal of impacted ear wax222$8,971$35
Diagnostic exam of voice box using a flexible endoscope40$4,653$113
Control of bleeding of nose using an endoscope19$4,484$214
Short return visit55$2,866$45
New patient visit (15+ min)47$2,393$51
New patient visit (60+ min)12$2,247$187
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's121$1,959$14
Telephone medical discussion with physician, 11-20 minutes13$1,174$78

Who their Medicare patients are

720 Original Medicare patients in 2024. Average age 77 · Under 65 2% · 85 and older 17% · Women 59% · Also on Medicaid 11% · Health risk score 1.11. At or below the middle of the specialty; the typical otolaryngology clinician is at 1.19.

Conditions among them: High blood pressure 67% · Coronary heart disease 36% · Diabetes 23% · Depression 20% · Cancer 17% · Atrial fibrillation 16% · Chronic kidney disease 14% · Heart failure 13% · COPD 12% · Stroke 11% · Dementia 8%.

The office billed $1,568,251, Medicare allowed $330,350 and paid $251,953; for 2,067 services of 66 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20247202,067771.11$1,568,251$251,953
2023495976761.18$542,749$93,432
202279145711.28$38,406$10,520

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 15 services

Original Medicare services billed in 2023
Diagnostic exam of nasal passages using an endoscope117$22,159$172
Short return visit (20+ min)77$8,066$78
Removal of impacted ear wax169$7,864$39
Return visit (30+ min)58$7,526$109
New patient visit (45+ min)46$6,456$140
New patient visit (30+ min)56$5,324$95
Biopsy or removal of nasal polyp or tissue using an endoscope20$4,023$192
Short return visit61$3,171$50
Diagnostic exam of voice box using a flexible endoscope26$2,939$113
New patient visit (15+ min)40$2,384$60
Exam to assess movement of vocal cord flaps using an endoscope11$1,780$162
Diagnostic exam of nasal passages using an endoscope59$1,351$22
Short return visit (20+ min)20$1,133$54
New patient visit (45+ min)11$1,131$103
Return visit (30+ min)12$752$63

2022: 5 services

Original Medicare services billed in 2022
Biopsy or removal of nasal polyp or tissue using an endoscope12$2,491$192
Diagnostic exam of nasal passages using an endoscope60$1,533$25
New patient visit (45+ min)12$1,460$122
Return visit (30+ min)16$1,437$90
Short return visit (20+ min)22$1,270$58

Drugs they prescribed that Part D paid

$31,915

Pharmacies billed $31,915 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 3% of their Part D prescriptions (25 of 925) in 2024. At or below the middle of the specialty; the typical otolaryngology clinician is at 4%.

874 generic and 51 brand-name prescriptions · $31,915 in drug cost · 42 antibiotic prescriptions to 36 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Ipratropium73$6,263$35
Azelastine125$5,729$24
Ciprofloxacin-Dexamethasone32$5,508$128
Lansoprazole43$2,710$46
Fluocinolone Acetonide Oil29$1,578$33
See all 13 drugs
Every Part D drug this clinician prescribed
Ipratropium73$6,263$35
Azelastine125$5,729$24
Ciprofloxacin-Dexamethasone32$5,508$128
Lansoprazole43$2,710$46
Fluocinolone Acetonide Oil29$1,578$33
Fluticasone Propionate33$812$14
Mupirocin51$444$8
Amoxicillin-Clavulanate Potass26$309$10
Oxycodone-Acetaminophen21$152$7
Gabapentin13$109$7
Prednisone21$99$5
Methylprednisolone15$88$6
Lorazepam12$20$1

Year by year

Part D prescribing by year
20249253793% (25)6%$31,915
20233621913% (11)7%$40,711
20225935NoneNone$3,342

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 8 drugs

Part D drugs prescribed in 2023
Azelastine82$2,378$29
Ciprofloxacin-Dexamethasone13$2,128$164
Ipratropium53$2,004$38
Lansoprazole28$1,233$44
Fluocinolone Acetonide Oil21$1,162$55
Fluticasone Propionate26$534$21
Mupirocin30$246$8
Amoxicillin-Clavulanate Potass17$225$13

2022: 2 drugs

Part D drugs prescribed in 2022
Azelastine12$653$54
Fluticasone Propionate11$116$11

Money from drug and device companies

$3,560 in 2025

Industry payments by year
2025817$2,600$3,560
2024934$2,608$5,051
202356$300$542
202246None$351

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Aerin MedicalVivaer Stylus$3,033
6 payments
  • Meals for Vivaer Stylus · 2025-09-16 · $149
  • Consulting for Vivaer Stylus · 2025-07-11 · $400
  • Travel for Vivaer Stylus · 2025-04-29 · $276
  • Consulting for Vivaer Stylus · 2025-04-29 · $600
  • Consulting for Vivaer Stylus · 2025-04-29 · $1,600
  • Meals for Vivaer Stylus · 2025-04-29 · $8
Integra LifeSciencesAcclarent Aera$148
1 payment
  • Meals for Acclarent Aera · 2025-07-11 · $148
GlaxoSmithKlineNucala$126
4 payments
  • Meals for Nucala · 2025-08-26 · $34
  • Meals for Nucala · 2025-05-13 · $32
  • Meals for Nucala · 2025-03-26 · $31
  • Meals for Nucala · 2025-02-26 · $29
AxogenNone$119
1 payment
  • Meals · 2025-01-04 · $119
GenzymeDupixent$54
2 payments
  • Meals for Dupixent · 2025-11-18 · $30
  • Meals for Dupixent · 2025-04-08 · $24
Merz PharmaceuticalsXeomin$46
1 payment
  • Meals for Xeomin · 2025-01-13 · $46
See all 17 published payments
Every published payment
GenzymeMeals · 2025-11-18Dupixent$30
Aerin MedicalMeals · 2025-09-16Vivaer Stylus$149
GlaxoSmithKlineMeals · 2025-08-26Nucala$34
Optinose USMeals · 2025-08-04Xhance$17
Integra LifeSciencesMeals · 2025-07-11Acclarent Aera$148
Aerin MedicalConsulting · 2025-07-11Vivaer Stylus$400
GlaxoSmithKlineMeals · 2025-05-13Nucala$32
Aerin MedicalTravel · 2025-04-29Vivaer Stylus$276
Aerin MedicalConsulting · 2025-04-29Vivaer Stylus$600
Aerin MedicalConsulting · 2025-04-29Vivaer Stylus$1,600
Aerin MedicalMeals · 2025-04-29Vivaer Stylus$8
GenzymeMeals · 2025-04-08Dupixent$24
GlaxoSmithKlineMeals · 2025-03-26Nucala$31
MDD US OperationsMeals · 2025-03-05Gocovri$17
GlaxoSmithKlineMeals · 2025-02-26Nucala$29
Merz PharmaceuticalsMeals · 2025-01-13Xeomin$46
AxogenMeals · 2025-01-04None$119
See earlier years (2024, 2023, 2022)

2024: $5,051

Payments by company in 2024
Aerin MedicalVivaer Stylus$3,789
17 payments
  • Meals for Vivaer Stylus · 2024-12-03 · $32
  • Consulting for Vivaer Stylus · 2024-11-30 · $800
  • Consulting for Vivaer Stylus · 2024-11-30 · $1,200
  • Consulting for Vivaer Stylus · 2024-11-30 · $200
  • Consulting for Vivaer Stylus · 2024-11-22 · $408
  • Meals for Vivaer Stylus · 2024-09-30 · $172
  • Meals for Vivaer Stylus · 2024-08-22 · $148
  • Meals for Vivaer Stylus · 2024-08-22 · $29
  • Meals for Vivaer Stylus · 2024-05-20 · $26
  • Travel for Vivaer Stylus · 2024-03-31 · $276
  • Meals for Vivaer Stylus · 2024-03-31 · $50
  • Meals for Vivaer Stylus · 2024-03-02 · $62
  • Meals for Vivaer Stylus · 2024-03-02 · $33
  • Meals for Vivaer Stylus · 2024-03-02 · $21
  • Meals for Vivaer Stylus · 2024-03-02 · $98
  • Meals for Vivaer Stylus · 2024-03-01 · $74
  • Meals for Vivaer Stylus · 2024-03-01 · $159
StrykerScopis Ent$641
4 payments
  • Meals for Scopis Ent · 2024-10-29 · $277
  • Meals for Alphavent · 2024-10-03 · $170
  • Meals for Salvation · 2024-09-03 · $175
  • Meals for N/A · 2024-06-05 · $20
MedtronicPropel$197
2 payments
  • Meals for Propel · 2024-12-17 · $101
  • Meals for Propel · 2024-02-08 · $96
Regeneron Healthcare SolutionsDupixent$157
2 payments
  • Meals for Dupixent · 2024-04-16 · $118
  • Meals for Dupixent · 2024-01-24 · $39
GlaxoSmithKlineNone$79
1 payment
  • Meals · 2024-09-27 · $79
GenzymeDupixent$73
3 payments
  • Meals for Dupixent · 2024-11-13 · $21
  • Meals for Dupixent · 2024-07-24 · $24
  • Meals for Dupixent · 2024-05-22 · $28
Optinose USXhance$66
3 payments
  • Meals for Xhance · 2024-09-24 · $22
  • Meals for Xhance · 2024-05-22 · $17
  • Meals for Xhance · 2024-04-29 · $27
Ipsen BiopharmaceuticalsDysport$34
1 payment
  • Meals for Dysport · 2024-12-18 · $34
AxogenAvance Nerve Graft$15
1 payment
  • Meals for Avance Nerve Graft · 2024-11-11 · $15

2023: $542

Payments by company in 2023
Aerin MedicalVivaer Stylus$321
2 payments
  • Consulting for Vivaer Stylus · 2023-12-26 · $300
  • Meals for Vivaer Stylus · 2023-09-25 · $21
Merz PharmaceuticalsXeomin$133
1 payment
  • Meals for Xeomin · 2023-09-20 · $133
StrykerXpress Ent Dilation System$52
1 payment
  • Meals for Xpress Ent Dilation System · 2023-10-11 · $52
GlaxoSmithKlineNucala$20
1 payment
  • Meals for Nucala · 2023-12-07 · $20
Smith+NephewGrafix Pl$16
1 payment
  • Meals for Grafix Pl · 2023-10-23 · $16

2022: $351

Payments by company in 2022
StrykerXpress Ent Dilation System$183
3 payments
  • Meals for Xpress Ent Dilation System · 2022-10-15 · $16
  • Meals for Xpress Ent Dilation System · 2022-10-15 · $15
  • Meals for Xpress Ent Dilation System · 2022-09-08 · $153
GlaxoSmithKlineNucala$99
1 payment
  • Meals for Nucala · 2022-10-11 · $99
Aerin MedicalNone$39
1 payment
  • Meals · 2022-10-12 · $39
MedtronicMazor X System$30
1 payment
  • Meals for Mazor X System · 2022-12-11 · $30

Professional record

NPI
1467108647
Licence
CA A176533California A176533: Current · expires 2028-02-29
Trained
Un of British Columbia, Faculty of Medicine, 2015
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Otolaryngology (207Y00000X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2022-02-25
NPI last updated
2024-01-25
NPI record certified
2024-01-25

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305